Want to join the conversation?
$CERN 2Q15 Q&A: Charles from Cohen asked about revenue cycle management. Marc replied from revenue cycle, I think we're very happy with where we are relative to the solutions that we have out there and relative to the sort of the initial Rev works in revenue cycle activities.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?